Company Filing History:
Years Active: 2010
Title: Anna M Blom: Innovator in Age-Related Macular Degeneration Research
Introduction
Anna M Blom is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of biomedical research, particularly in the area of age-related macular degeneration (AMD). Her innovative work focuses on identifying agents that can inhibit specific binding interactions related to this condition.
Latest Patents
Anna M Blom holds a patent for "Screening assays for binding antagonists of the AMD-associated variant of factor H (H384)." This invention relates to identifying agents that preferentially inhibit binding to targets such as heparin of the H384 allotypic variant of human complement Factor H. This variant is associated with AMD, and the invention aims to develop treatments by targeting the differential binding of the allotypic variants.
Career Highlights
Anna is affiliated with the University of Manchester, where she conducts her research. Her work has garnered attention for its potential impact on developing therapeutic strategies for AMD.
Collaborations
She has collaborated with notable colleagues, including Anthony Day and Simon J Clark, to advance her research initiatives.
Conclusion
Anna M Blom's innovative contributions to AMD research highlight her role as a key inventor in the field. Her patent work demonstrates the potential for developing targeted treatments that could significantly improve patient outcomes.